Therapeutic Area
Neuroscience
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

The Lancet Neurology
Neuroscience
Platform
Safety and efficacy of trehalose in amyotrophic lateral sclerosis (HEALEY ALS Platform Trial): an adaptive, phase 2/3, double-blind, randomised, placebo-controlled trial
June 1, 2025
DOI: 10.1016/S1474-4422(25)00173-5

Wiley Online Library
Neuroscience
Platform
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial. Muscle Nerve.
May 26, 2025
DOI: 10.1002/mus.28442
The Lancet Neurology
Neuroscience
Dose Ranging
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial
February 24, 2025
DOI: 10.1016/S1474-4422(24)00456-3
JAMA Neurology
Neuroscience
Platform
Verdiperstat in Amyotrophic Lateral Sclerosis Results From the Randomized HEALEY ALS Platform Trial
February 17, 2025
doi:10.1001/jamaneurol.2024.5249
JAMA
Neuroscience
Platform
CNM-Au8 in Amyotrophic Lateral Sclerosis The HEALEY ALS Platform Trial
February 17, 2025
doi:10.1001/jama.2024.27643
JAMA Network Open
Neuroscience
Platform
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis A Randomized Clinical Trial
February 17, 2025
doi:10.1001/jamanetworkopen.2024.59058
JAMA
Neuroscience
Platform
Pridopidine in Amyotrophic Lateral Sclerosis The HEALEY ALS Platform Trial
February 17, 2025
doi:10.1001/jama.2024.26429
Stroke
Neuroscience
Stroke
Platform
Adaptive Platform Trials in Stroke
December 20, 2024
doi.org/10.1161/STROKEAHA.124.045754
American Heart Association Journal
Neuroscience
Stroke
Adaptive Clinical Trials in Stroke
October 22, 2024
DOI: 10.1161/STROKEAHA.124.046125
JAMA
Neuroscience
Enrichment
Writing Committee for the TESLA Investigators; Yoo AJ et al. Thrombectomy for Stroke With Large Infarct on Noncontrast CT: The TESLA Randomized Clinical Trial.
September 24, 2024
doi: 10.1001/jama.2024.13933
The New England Journal of Medicine
Neuroscience
Other
Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke
September 5, 2024
doi: 10.1056/NEJMoa2314779.
The New England Journal of Medicine
Neuroscience
Enrichment
Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage
April 11, 2024
doi: 10.1056/NEJMoa2308440.